Clinical Trial Update: A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Doxil, Vincristine and Dexamethasone with or without CC-5013 (lenalidomide) in relapsed or refractory multiple myeloma is completed. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Revlimid (lenalidomide)
• Vincristine (vincristine)

Snippet

Sponsor: Celgene Corporation | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED